Atlas Trials

Evaluation of PD-L1 Expression and Immune Infiltration in High-risk Non Muscle Invasive Bladder Cancer

Clinical trial NCT04726735 · COMPLETED

Trial details

NCT number
NCT04726735
Sponsor
University Hospital, Bordeaux
Status
COMPLETED
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2020-03-16
Primary completion
2020-05-14
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.